EXPRESSION OF THE CELL-ADHESION MOLECULE CD44 IN GASTRIC ADENOCARCINOMAS

被引:64
作者
WASHINGTON, K [1 ]
GOTTFRIED, MR [1 ]
TELEN, MJ [1 ]
机构
[1] DUKE UNIV,MED CTR,DEPT MED,DURHAM,NC 27710
关键词
GASTRIC ADENOCARCINOMA; CD44; IMMUNOHISTOCHEMISTRY; CELL ADHESION MOLECULES;
D O I
10.1016/0046-8177(94)90063-9
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
CD44, an integral membrane glycoprotein expressed by many cell types, serves as the principal transmembrane hyaluronate receptor and may be a determinant of metastatic and invasive behavior in carcinomas. The expression of CD44 in 23 gastric adenocarcinoma and 12 peptic ulcer disease (PUD) resection specimens and gastric carcinoma cell lines HS746t and KATO III was examined by immunohistochemistry using the murine monoclonal antibody A3D8 on formalin-fixed, paraffin-embedded tissue or cells. Western blot analysis of whole cell lysates of KATO III and HS746t cells showed protein bands at 85 to 90 kd with KATO III cells expressing an additional band at 145 kd. In normal stomach gastric epithelium was negative. In PUD foveolar epithelium was focally positive, but staining did not correlate with the extent of gastritis. In carcinoma cases intensity of staining was progressively stronger comparing intestinal metaplasia with dysplasia with intramucosal carcinoma. Invasive carcinoma was invariably more strongly positive than dysplasia or intramucosal carcinoma. Twelve adenocarcinomas were weakly positive and 11 were strongly positive. The staining intensity of metastases (12 cases) was the same or weaker than the primary tumor. For the 12 patients whose carcinomas were weakly positive, mean length of survival for the six who died was 23.3 months. Five of the 11 patients whose carcinomas strongly expressed CD44 died within the study period with a mean length of survival of 11.0 months. A key consequence of CD44 overexpression in gastric carcinomas may be development of the invasive phenotype and strong expression may indicate a poorer prognosis. Copyright (C) 1994 by W.B. Saunders Company
引用
收藏
页码:1043 / 1049
页数:7
相关论文
共 22 条
[1]   CD44 IS THE PRINCIPAL CELL-SURFACE RECEPTOR FOR HYALURONATE [J].
ARUFFO, A ;
STAMENKOVIC, I ;
MELNICK, M ;
UNDERHILL, CB ;
SEED, B .
CELL, 1990, 61 (07) :1303-1313
[2]   HOMING RECEPTORS AND VASCULAR ADDRESSINS - CELL-ADHESION MOLECULES THAT DIRECT LYMPHOCYTE TRAFFIC [J].
BERG, EL ;
GOLDSTEIN, LA ;
JUTILA, MA ;
NAKACHE, M ;
PICKER, LJ ;
STREETER, PR ;
WU, NW ;
ZHOU, D ;
BUTCHER, EC .
IMMUNOLOGICAL REVIEWS, 1989, 108 :5-18
[3]   IMMUNOCYTOCHEMISTRY IS AUTOMATED - DEVELOPMENT OF A ROBOTIC WORKSTATION BASED UPON THE CAPILLARY ACTION PRINCIPLE [J].
BRIGATI, DJ ;
BUDGEON, LR ;
UNGER, ER ;
KOEBLER, D ;
CUOMO, C ;
KENNEDY, T ;
PERDOMO, JM .
JOURNAL OF HISTOTECHNOLOGY, 1988, 11 (03) :165-183
[4]   HUMAN KERATINOCYTES EXPRESS A NEW CD44 CORE PROTEIN (CD44E) AS A HEPARAN-SULFATE INTRINSIC MEMBRANE PROTEOGLYCAN WITH ADDITIONAL EXONS [J].
BROWN, TA ;
BOUCHARD, T ;
STJOHN, T ;
WAYNER, E ;
CARTER, WG .
JOURNAL OF CELL BIOLOGY, 1991, 113 (01) :207-221
[5]   MOLECULAR-CLONING OF CD44R1 AND CD44R2, 2 NOVEL ISOFORMS OF THE HUMAN CD44 LYMPHOCYTE HOMING RECEPTOR EXPRESSED BY HEMATOPOIETIC-CELLS [J].
DOUGHERTY, GJ ;
LANSDORP, PM ;
COOPER, DL ;
HUMPHRIES, RK .
JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 174 (01) :1-5
[6]   A HUMAN-LYMPHOCYTE HOMING RECEPTOR, THE HERMES ANTIGEN, IS RELATED TO CARTILAGE PROTEOGLYCAN CORE AND LINK PROTEINS [J].
GOLDSTEIN, LA ;
ZHOU, DFH ;
PICKER, LJ ;
MINTY, CN ;
BARGATZE, RF ;
DING, JF ;
BUTCHER, EC .
CELL, 1989, 56 (06) :1063-1072
[7]   A NEW VARIANT OF GLYCOPROTEIN CD44 CONFERS METASTATIC POTENTIAL TO RAT CARCINOMA-CELLS [J].
GUNTHERT, U ;
HOFMANN, M ;
RUDY, W ;
REBER, S ;
ZOLLER, M ;
HAUSSMANN, I ;
MATZKU, S ;
WENZEL, A ;
PONTA, H ;
HERRLICH, P .
CELL, 1991, 65 (01) :13-24
[8]   CD44 - A MOLECULE INVOLVED IN LEUKOCYTE ADHERENCE AND T-CELL ACTIVATION [J].
HAYNES, BF ;
TELEN, MJ ;
HALE, LP ;
DENNING, SM .
IMMUNOLOGY TODAY, 1989, 10 (12) :423-428
[9]  
HEIDER KH, 1993, CANCER RES, V53, P4197
[10]   A HUMAN HOMOLOG OF THE RAT METASTASIS-ASSOCIATED VARIANT OF CD44 IS EXPRESSED IN COLORECTAL CARCINOMAS AND ADENOMATOUS POLYPS [J].
HEIDER, KH ;
HOFMANN, M ;
HORS, E ;
VANDENBERG, F ;
PONTA, H ;
HERRLICH, P ;
PALS, ST .
JOURNAL OF CELL BIOLOGY, 1993, 120 (01) :227-233